According to Trinity Biotech 's latest financial reports the company's current EPS (TTM) is -$0.81. In 2022 the company made an earnings per share (EPS) of -$1.28 a decrease over its 2021 EPS that were of $0.04240.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.81 | -37.07% |
2022 | -$1.28 | -3128.3% |
2021 | $0.04240 | -113.93% |
2020 | -$0.30 | -78.07% |
2019 | -$1.39 | 31.3% |
2018 | -$1.06 | -44.69% |
2017 | -$1.91 | -56.77% |
2016 | -$4.42 | -572.33% |
2015 | $0.94 | 23.81% |
2014 | $0.76 | 71.04% |
2013 | $0.44 | -46.68% |
2012 | $0.83 | 12.15% |
2011 | $0.74 | -73.99% |
2010 | $2.84 | 407.5% |
2009 | $0.56 | -117.14% |
2008 | -$3.27 | 148.54% |
2007 | -$1.31 | -744.56% |
2006 | $0.20 | -65.31% |
2005 | $0.59 | -62.99% |
2004 | $1.59 | -22.6% |
2003 | $2.05 | 6.92% |
2002 | $1.92 | 287.1% |
2001 | $0.50 | -77.84% |
2000 | $2.24 | 12.38% |
1999 | $1.99 | 57.99% |
1998 | $1.26 | 77.04% |
1997 | $0.71 |